MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

0.8475 +0.0475 (+5.94%)
Streaming Delayed Price Updated: 3:59 PM EST, Mar 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Scinai Immunotherapeutics Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Releases Shareholder Letter
Via Investor Brand Network
Shining Spotlight on How Vitiligo Could Be Connected to Other Autoimmune Disorders
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Agreement for Million-Dollar Exercise of Outstanding Warrants
Via Investor Brand Network
Potential Complications of Untreated Psoriasis
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces January Analyst, Investor Webinar
Via Investor Brand Network
New Research Redefines Pathophysiology of Rheumatoid Arthritis, Paves Way for Precision Treatments
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Preclinical Results from Psoriatic Human Skin Trial
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announced Peer-Reviewed Journal Publishes Data Supporting NanoAbs
Via Investor Brand Network
Many Fellowship Programs for Infectious Disease Specialists Remain Unfilled in US
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Maturity Extension of EIB Finance Facility
Via Investor Brand Network
Autoimmunity Patients Face Cost, Diagnosis, Care Challenges
Via Investor Brand Network
New, Deadly Infectious Diseases Could Emerge as Climate Change Worsens
Via Investor Brand Network
Topics Climate Change
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receive $900K IIA Grant for New CDMO Business Unit
Via Investor Brand Network
Topics Economy
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Status Report on NASDAQ Compliance
Via Investor Brand Network
News headline image
Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
News headline image
Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q3 2023 Financial Report, Reports Possible Adjustment of Facility Terms by EIB
Via Investor Brand Network
News headline image
European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
News headline image
Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Study Identifies Immune Cells Responsible for Severe Asthma
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023
Via Investor Brand Network
News headline image
Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Showcase Its Boutique End-to-End CDMO Services at the Premier CPHI Barcelona Event
Via Investor Brand Network
Five Ways to Treat Infectious Diseases While Keeping Antimicrobial Resistance in Check
Via Investor Brand Network
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Promising Results in Its Pursuit of Safe, Effective Treatments for Large, Underserved Population of Plaque Psoriasis Patients
Via Investor Brand Network
Researchers ID Biomarker That Could Improve Autoimmune Disease Treatment
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
Syndromic Testing Could Transform Infectious Disease Diagnosis
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story